Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

9th Annual Drug Delivery Partnerships Convenes in San Diego to Discuss Trends in Growing Drug Delivery Market.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- The 9th Annual Drug Delivery Partnerships (DDP (Distributed Data Processing) See distributed processing.

DDP - Distributed Data Processing
) conference announces its Keynote Addresses will focus on improving the environment for innovation in science and technology, the role of advanced drug delivery in growing a specialty pharma company, a new model for specialty pharmaceuticals, and lifecycle management strategies. DDP will take place on January 24-26 at the Sheraton San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay.  Hotel and Marina in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
.

A special "Partnerships" Address will reveal successful partnering strategies and the annual Wall Street Address will cover changes, opportunity and the future of the drug delivery and specialty pharma market. A Senior Executive Keynote Panel with representatives from Biogen Idec Biogen Idec, Inc. (NASDAQ: BIIB) is a biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen and San Diego, California-based Idec , Solstice solstice (sŏl`stĭs) [Lat.,=sun stands still], in astronomy, either of the two points on the ecliptic that lie midway between the equinoxes (separated from them by an angular distance of 90°).  Neurosciences, Inc and Viropharma will discuss drug delivery as a strategy to maximize the lifecycle, value and profit of existing portfolios. The Visionary Panel represented by Eli Lilly Eli Lilly can refer to:
  • Eli Lilly and Company, a global pharmaceutical company
  • Colonel Eli Lilly (1839-1898), founder of Eli Lilly and Company
  • Eli Lilly (industrialist) (1885-1977), former president of Eli Lilly and Company
 & Company, Pfizer, Amgen, Eurand and Schering AG, will offer insights on opportunities, challenges and trends in the drug delivery industry.

DDP's concurrent tracks will focus on

--Strategic Lifecycle Management

--Business Development for Pharma, Specialty Pharma and Drug Delivery

--Delivering to Biotechnology

--Responding to the Generic Drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name.  Market

--Innovative Technology That Fuels Deals - Day I and Day II

Innovative partnerships between pharmaceutical, specialty pharma and drug delivery companies are key when extending shelf life of products facing patent expirations. The application of drug delivery solutions to existing products provides pharmaceutical companies with competitive and financial advantages. Drug delivery systems can make drug therapy more convenient by simplifying dosing and while improving patient compliance.

"The U.S. market for drug delivery systems is expected to grow by nine percent annually through 2007," said Mark DuVal, Partner, Klepinski & DuVal. "For large pharmas, life-cycle management means taking a holistic look at their products and assembling a multi-disciplinary team to engage in solutions--from drug delivery technologies to OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 switches. For drug delivery companies it means having a technology that is more than just on paper with limited bench testing and a proof of principle less than definitive. For specialty pharma companies it means finding those hidden-gem molecules and licensing them in and developing a niche market A niche market also known as a target market is a focused, targetable portion (subset) of a market sector.

By definition, then, a business that focuses on a niche market is addressing a need for a product or service that is not being addressed by mainstream providers.
 for them."

"Life-cycle management is a critical issue, and it will be a hot topic at DDP this year as it further solidifies the relationship between big pharma, drug delivery companies and specialty pharma companies," said Lesly Atlas, Event Director for DDP. "We are pleased to bring renowned pharmaceutical, drug delivery, specialty pharma, legal and regulatory experts together in order to discuss new business models, the effects of paradigm shifts A dramatic change in methodology or practice. It often refers to a major change in thinking and planning, which ultimately changes the way projects are implemented. For example, accessing applications and data from the Web instead of from local servers is a paradigm shift. See paradigm. , survey new technologies and to discuss partnering and competitive strategies."

About Drug Delivery Partnerships

Drug Delivery Partnerships(TM) (DDP) is the only international networking event of its kind in the industry dedicated solely to fostering business alliances between biopharmaceutical and drug delivery companies.

DDP is held by the Institute for International Research, the world's largest conference company, and has provided an annual forum for bringing existing and potential partners together to initiate and expand deals that further their business. The event attracts over 600 influential professionals from the U.S. and abroad each year and is considered the premier deal-making conference for the drug delivery industry. DDP's partnerships with key industry research firms and publications, such as Frost & Sullivan and Drug Delivery Technology magazine, along with its own dedicated research, allow it to deliver up-to-date information on the science and the business to drug delivery professionals. More information on the annual event can be found at http://www.drugdeliverypartnerships.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 5, 2005
Words:577
Previous Article:S3 Investment Company Announces Acquisition of TSPartner, Inc.
Next Article:Fitch Rates Tucson, Arizona's $55.1MM Water Rev Rfdg Bonds 'AA'.



Related Articles
AlphaRx to Present Research Paper at the 28th International Symposium on Controlled Release of Bioactive Materials Conference.
A powerful affiliation for corporate RE professionals.
ADVISORY/California Leaders Convene at International Forum to Discuss Trends in $50 Billion and Rapidly Growing Drug Delivery Market.
8th Annual Drug Delivery Partnerships Conference Hosts Forum to Discuss Effect of Market Changes on Critical Drug Delivery Sector.
From Novel Drug Delivery Technologies to Spin-Off Strategies, the Drug Delivery Industry Gears up for Premier Industry Event.
REMINDER/California Leaders Convene at International Forum to Discuss Trends in $50 Billion and Rapidly Growing Drug Delivery Market.
NovoStent Corp. to Present at Medtech Insight's ``Investment In Innovation'' Conference.
9th Annual Drug Delivery Partnerships Forum Explores Partnerships and Innovative Technology.
Research and Markets: Topics such as 'Current Status of Controlled Drug Delivery' are examined in this new Drug Delivery Companies Report 2005.
The World's Market for Drug Delivery Technology is Worth in Excess of US$25 Billion.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles